STANDARD BIOTOOLS INC. (LAB) › Operating IncomeSTANDARD BIOTOOLS INC. (LAB) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2009: -$18.04M2010: -$14.57M2011: -$18.57M2012: -$18.07M2013: -$18.65M2014: -$51.84M2015: -$50.16M2016: -$73.19M2017: -$58.36M2018: -$48.16M2019: -$51.84M2020: -$51.04M2021: -$67.46M2022: -$116.20M2023: -$76.60M2024: -$127.48M2025: -$110.25M-$110.25M2009Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$110.25M+13.5%2024-$127.48M-66.4%2023-$76.60M+34.1%2022-$116.20M-72.3%2021-$67.46M-32.2%2020-$51.04M+1.5%2019-$51.84M-7.6%2018-$48.16M+17.5%2017-$58.36M+20.3%2016-$73.19M-45.9%2015-$50.16M+3.2%2014-$51.84M-177.9%2013-$18.65M-3.2%2012-$18.07M+2.7%2011-$18.57M-27.4%2010-$14.57M+19.2%2009-$18.04M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share